CHC
GILD icon

City Holding Co’s Gilead Sciences GILD Stock Holding History

City Holding Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-135
Closed -$15K – 602
2025
Q3 		$15K Hold
135
– – ﹤0.01% 449
2025
Q2 		$15K Sell
135
-165
-55% -$17.6K ﹤0.01% 396
2025
Q1 		$33.6K Hold
300
– – ﹤0.01% 348
2024
Q4 		$27.7K Hold
300
– – ﹤0.01% 351
2024
Q3 		$25.2K Sell
300
-453
-60% -$34.6K ﹤0.01% 350
2024
Q2 		$51.7K Sell
753
-650
-46% -$43.4K 0.01% 306
2024
Q1 		$103K Hold
1,403
– – 0.02% 269
2023
Q4 		$114K Sell
1,403
-163
-10% -$12.7K 0.02% 259
2023
Q3 		$117K Sell
1,566
-52
-3% -$4K 0.02% 249
2023
Q2 		$125K Sell
1,618
-35
-2% -$2.79K 0.02% 255
2023
Q1 		$137K Hold
1,653
– – 0.02% 245
2022
Q4 		$142K Sell
1,653
-35
-2% -$2.77K 0.03% 242
2022
Q3 		$104K Sell
1,688
-100
-6% -$6.31K 0.02% 254
2022
Q2 		$111K Hold
1,788
– – 0.02% 249
2022
Q1 		$106K Hold
1,788
– – 0.02% 262
2021
Q4 		$108K Sell
1,788
-549
-23% -$37.8K 0.02% 261
2021
Q3 		$163K Sell
2,337
-88
-4% -$6.18K 0.03% 231
2021
Q2 		$167K Sell
2,425
-3,265
-57% -$218K 0.03% 217
2021
Q1 		$368K Sell
5,690
-464
-8% -$29.9K 0.07% 165
2020
Q4 		$359K Sell
6,154
-6,964
-53% -$420K 0.08% 153
2020
Q3 		$829K Buy
13,118
+88
+0.7% +$6.1K 0.19% 120
2020
Q2 		$1M Sell
13,030
-150
-1% -$11.5K 0.25% 109
2020
Q1 		$985K Sell
13,180
-100
-0.8% -$6.91K 0.3% 102
2019
Q4 		$863K Sell
13,280
-1,385
-9% -$90.2K 0.2% 114
2019
Q3 		$929K Sell
14,665
-305
-2% -$19.9K 0.24% 104
2019
Q2 		$1.01M Sell
14,970
-1,715
-10% -$113K 0.27% 104
2019
Q1 		$1.08M Sell
16,685
-655
-4% -$43.5K 0.31% 97
2018
Q4 		$1.08M Sell
17,340
-3,865
-18% -$270K 0.35% 92
2018
Q3 		$1.64M Sell
21,205
-760
-3% -$57.4K 0.47% 80
2018
Q2 		$1.56M Sell
21,965
-1,525
-6% -$108K 0.48% 78
2018
Q1 		$1.77M Sell
23,490
-450
-2% -$35.8K 0.57% 65
2017
Q4 		$1.72M Sell
23,940
-515
-2% -$39.1K 0.54% 69
2017
Q3 		$1.98M Buy
24,455
+560
+2% +$42.8K 0.66% 53
2017
Q2 		$1.69M Buy
23,895
+914
+4% +$60.8K 0.6% 60
2017
Q1 		$1.56M Buy
22,981
+2,450
+12% +$172K 0.58% 61
2016
Q4 		$1.47M Buy
20,531
+4,695
+30% +$349K 0.57% 62
2016
Q3 		$1.25M Buy
15,836
+2,695
+21% +$219K 0.54% 65
2016
Q2 		$1.1M Buy
13,141
+4,373
+50% +$388K 0.49% 73
2016
Q1 		$805K Buy
8,768
+1,975
+29% +$178K 0.4% 85
2015
Q4 		$687K Buy
6,793
+717
+12% +$74.6K 0.35% 90
2015
Q3 		$597K Buy
6,076
+125
+2% +$13.9K 0.33% 93
2015
Q2 		$697K Buy
5,951
+4,475
+303% +$489K 0.35% 91
2015
Q1 		$145K Hold
1,476
– – 0.07% 147
2014
Q4 		$139K Buy
1,476
+200
+16% +$20.7K 0.07% 149
2014
Q3 		$136K Hold
1,276
– – 0.08% 146
2014
Q2 		$117K Hold
1,276
– – 0.07% 154
2014
Q1 		$90K Hold
1,276
– – 0.05% 161
2013
Q4 		$96K Buy
+1,276
New +$88.8K 0.06% 158

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

City Holding Co's GILD Position: Q4 2025 in Review

City Holding Co sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 135 shares — an estimated $15K sold.

City Holding Co first reported a position in GILD in Q4 2013 and held it in 48 quarters. The position peaked at $1.98M in Q3 2017. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • City Holding Co reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • City Holding Co sold 135 Gilead Sciences shares in Q4 2025, an estimated $15K.
  • City Holding Co first reported a position in Gilead Sciences in Q4 2013 and held it in 48 quarters.
  • City Holding Co's Gilead Sciences position peaked at $1.98M in Q3 2017.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on City Holding Co's 13F filing for Q4 2025, filed 22 Jan 2026.